SP playing a little bit of catch up at the moment. Maybe some MSB money is flowing through. Still can't believe the discrepancy between the market cap for the 2 company though.
Had sometime to think about the survival benefit in aGVHD after 2 years which is striking. Does anybody know whether there is any plan in offering 'booster' dose to the study population to make the effect even longer lasting.
Ann: Cynata Investor Presentation, page-59
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $38.84M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 20.5¢ | $11.17K | 53.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6162 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 13800 | 1 |
View Market Depth
| Last trade - 14.25pm 30/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |